News

Cummins price target lowered to $315 from $407 at Baird
Baird lowered the firm’s price target on Cummins (CMI) to $315 from $407 and keeps a Neutral rating on the shares. The firm reverted to a more ...
Cytokinetics reiterated top pick after Bristol failure at H.C. Wainwright
H.C. Wainwright reiterates Cytokinetics (CYTK) as a top pick after Bristol-Myers (BMY) announced that the Phase 3 ODYSSEY-HCM clinical trial ...